|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provide by (used in) operating activities: | |||||
| Depreciation and amortization expense | |||||
| Accrued interest on marketable securities, net | |||||
| Stock-based compensation expense | |||||
| Gain from revaluation of contingent consideration | |||||
| Loss on financial instruments | |||||
| Amortization of discount and debt issuance costs | |||||
| Gain on financial instruments | |||||
| Loss on extinguishment of debt | |||||
| Loss on impairment of intangible assets | |||||
| Gain on lease modification | |||||
| Deferred taxes | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Deferred costs | |||||
| Deferred rent and tenant allowances | |||||
| Deferred revenues | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of marketable securities | |||||
| Proceeds from sales, maturities, and redemptions of marketable securities | |||||
| Purchases of property and equipment | |||||
| Capitalized software development costs | |||||
| Acquisition of business, net of cash acquired | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of long-term debt | |||||
| Payments on revolving loan | |||||
| Principal payments on debt | |||||
| Payment of holdback funds from acquisition | |||||
| Debt issuance costs paid | |||||
| Repurchase of common stock | |||||
| Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and commissions | |||||
| Payment of Series B dividend | |||||
| Proceeds from ESPP issuance | |||||
| Deferred IPO issuance costs paid | |||||
| Proceeds from issuance of convertible senior notes | |||||
| Proceeds from borrowing under revolving loan | |||||
| Purchase of capped calls | |||||
| Payments for taxes related to net settlement of equity awards | |||||
| Proceeds from stock option exercises | |||||
| Proceeds from exercise of warrants | |||||
| Net cash provided by (used in) financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for taxes (states) | |||||
| Cash paid for taxes (states) | |||||
| Cash paid for taxes (foreign) | |||||
Loading...